Search Login Register
Neoplasms
(Cancer)
Summary
Description:
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Also Known As:
Cancer; Tumor; Tumors; Cancers; Neoplasm Show All >>
Networked: 649836
relevant articles (32907 outcomes,
84134 trials/studies)
for this Disease
Key Drugs and Agents for Neoplasms
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Cisplatin (Platino)
:
816 outcomes 1447 studies in 8936 results
:
FDA 6
Generic
-
Antigens
:
801 outcomes 2169 studies in 23592 results
: IBA
-
DNA (Deoxyribonucleic Acid)
:
626 outcomes 2430 studies in 27338 results
: IBA
-
Doxorubicin (Adriamycin)
:
584 outcomes 847 studies in 6601 results
:
FDA 12
Generic
-
Paclitaxel (Taxol)
:
490 outcomes 1003 studies in 4577 results
:
FDA 13
Generic
-
Biological Markers (Surrogate Marker)
:
398 outcomes 1585 studies in 10462 results
: IBA
-
Fluorouracil (Carac)
:
398 outcomes 821 studies in 5142 results
:
FDA 33
Generic
-
Interleukin-2 (IL2)
:
367 outcomes 573 studies in 4188 results
: IBA
-
Vaccines
:
366 outcomes 464 studies in 3582 results
: IBA
-
1-phenyl-3,3-dimethyltriazene (PDT)
:
355 outcomes 367 studies in 2483 results
: IBA
Show All >>
Diseases Related to Neoplasms
-
Neoplasms (Cancer)
-
Neoplasm Metastasis (Metastasis)
-
Pain (Aches)
-
Breast Neoplasms (Breast Cancer)
-
Carcinoma (Carcinomatosis)
Show All >>
Key Therapies for Neoplasms
Efficacy Chart >>
-
Drug Therapy (Chemotherapy)
:
4136 outcomes 5899 studies in 53076 results
-
Radiotherapy
:
1551 outcomes 2219 studies in 22771 results
-
Heterologous Transplantation (Xenotransplantation)
:
1265 outcomes 2366 studies in 19277 results
-
Immunotherapy
:
1066 outcomes 1457 studies in 12577 results
-
Therapeutics
:
346 outcomes 492 studies in 5745 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.